↓ Skip to main content

Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series

Overview of attention for article published in Respiratory Research, June 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series
Published in
Respiratory Research, June 2021
DOI 10.1186/s12931-021-01775-z
Pubmed ID
Authors

Aikaterini Detoraki, Eugenio Tremante, Remo Poto, Emanuela Morelli, Giuseppe Quaremba, Francescopaolo Granata, Antonio Romano, Ilaria Mormile, Francesca Wanda Rossi, Amato de Paulis, Giuseppe Spadaro

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 17%
Other 3 10%
Student > Bachelor 3 10%
Student > Doctoral Student 2 7%
Student > Master 2 7%
Other 4 14%
Unknown 10 34%
Readers by discipline Count As %
Medicine and Dentistry 13 45%
Biochemistry, Genetics and Molecular Biology 2 7%
Business, Management and Accounting 1 3%
Unspecified 1 3%
Chemistry 1 3%
Other 1 3%
Unknown 10 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2024.
All research outputs
#14,288,653
of 25,392,582 outputs
Outputs from Respiratory Research
#1,323
of 3,064 outputs
Outputs of similar age
#193,052
of 454,785 outputs
Outputs of similar age from Respiratory Research
#29
of 80 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,064 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,785 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.